Distinguished BioPharma Executive Hari Kumar Joins BioVie Board of Directors and Purchases Company Stock
BEVERLY, MA--(Marketwired - May 10, 2017) - BioVie Inc. (OTCQB: BIVI), a clinical-stage company focused on the discovery, development, and commercialization of innovative drug therapies for liver disease, today welcomed Dr. Hari Kumar, a highly …